PhD defense: how Tet2 shapes breast cancer in aging.

A doctoral defense in cancer biology from the University of Zurich's PhD program is open to the public. Doctoral candidate Nagihan Gizay Gönüllü examines how Tet2-clonal hematopoiesis promotes breast cancer progression during aging, while Dnmt3a-CH inhibits it. The defense takes place in Kleiner Hörsaal OST (HOER B5) at University Hospital Zurich. The Cancer Biology PhD Program at UZH organizes such defenses as part of its research training.